NBC “Nightly News” anchor Lester Holt could retire next year — and his would-be successor, Tom Llamas, “waits impatiently” for his exit in what looks like a “slow motion coup d’état ...
By Catherine Hong John Adams reviews “Every Valley,” Charles King’s new book about the artistic, social and political forces surrounding one of the greatest pieces of music ever created.
The legislative chamber was overcome with applause when New Brunswick's lieutenant-governor, smiling wide, addressed Susan Holt for the first time as "Madam Premier." Holt, a Liberal who won ...
Justin Brownlee and Stephen Holt torched the opposing side from beyond the arc, steering Barangay Ginebra to a 106-92 win over TNT in Game 4 of the PBA Season 49 Governors' Cup finals on Sunday at the ...
Reading picks from Book Review editors, guaranteed to suit any mood. By The New York Times Books Staff Novels by Haruki Murakami and Rebecca Yarros, memoirs by Angela Merkel and Cher ...
but this new book by brain surgeon Theodore H. Schwartz delves into whether they could have been saved. What actually goes on between a therapist and his or her client? Mental health is never out ...
Trump said Robert F. Kennedy Jr. may help shape his health care agenda. British health officials say they have identified four cases of the new, more infectious version of mpox that first emerged ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...
Oct. 22, 2024 — A study suggests that menopausal hormone therapy (MHT) might have moderate effects on brain health, but this depends on past surgical history, the ... Why Breast Cancer Spreads ...
Kelly Main is a Marketing Editor and Writer specializing in digital marketing, online advertising and web design and development. Before joining the team, she was a Content Producer at Fit Small ...
Viking Therapeutics released new data on an obesity pill that may eventually compete with blockbuster shots from Eli Lilly and Novo Nordisk, stoking further takeout speculation for the company.